INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of HeartWare International, Inc. of Class Action Lawsuit & a Lead...
March 09 2016 - 1:22PM
Business Wire
The following statement is being issued by Levi & Korsinsky,
LLP:
To: All persons or entities who purchased or otherwise
acquired securities of HeartWare International, Inc.
(“HeartWare”) (NASDAQ: HTWR) between June
10, 2014 and January 11, 2016.
You are hereby notified that a securities class action
has been commenced in the USDC for the Southern District of New
York. If you purchased or otherwise acquired HeartWare securities
between June 10, 2014 and January 11, 2016, your rights may be
affected by this action. To get more information go to:
http://zlk.9nl.com/heartware.
The complaint alleges that during the Class Period, HeartWare
and certain of its senior executives made false and misleading
statements and omitted material information. In particular, it is
alleged that after the U.S. Food and Drug Administration issued a
Warning Letter identifying numerous manufacturing and other
regulatory failures at the Company’s sole manufacturing facility,
Defendants falsely assured investors that the Company had addressed
those problems, and that these concerns therefore posed no risk to
the clinical trials or timely approval of MVAD, a pump that
HeartWare is developing.
Following a series of disclosures regarding adverse effects in
certain clinical trial patients, shares of HeartWare have declined
from a close of $87.73 per share on June 25, 2014, to a close of
just $34.50 per share on January 22, 2016.
If you suffered a loss in HeartWare you have until
March 22, 2016 to request that the
Court appoint you as lead plaintiff. Your ability to share in any
recovery doesn’t require that you serve as a lead plaintiff. To
obtain additional information, contact Joseph E. Levi, Esq. either
via email at jlevi@zlk.com or by telephone at (212) 363-7500,
toll-free: (877) 363-5972, or visit
http://zlk.9nl.com/heartware.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, California, Connecticut, and Washington D.C. The
firm’s attorneys have extensive expertise and experience
representing investors in securities litigation involving financial
fraud, and have recovered hundreds of millions of dollars for
aggrieved shareholders. Attorney advertising. Prior results do not
guarantee similar outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160309006226/en/
Levi & Korsinsky, LLPEduard Korsinsky, Esq.Tel:
212-363-7500Toll Free: 877-363-5972Fax: 212-363-7171www.zlk.com
Heartware International, Inc. (MM) (NASDAQ:HTWR)
Historical Stock Chart
From Apr 2024 to May 2024
Heartware International, Inc. (MM) (NASDAQ:HTWR)
Historical Stock Chart
From May 2023 to May 2024